Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") highlights the potential for its DPXtm non-systemic immune educating platform to address the inherent limitations of lipid ...